Cleared Traditional

K142319 - SCIg60 Infuser, Infuset (FDA 510(k) Clearance)

May 2015
Decision
267d
Days
Class 2
Risk

K142319 is an FDA 510(k) clearance for the SCIg60 Infuser, Infuset. This device is classified as a Immunoglobulin G (igg) Infusion System (Class II - Special Controls, product code PKP).

Submitted by Emed Technologies Corporation (El Dorado Hills, US). The FDA issued a Cleared decision on May 14, 2015, 267 days after receiving the submission on August 20, 2014.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5725. An Immunoglobulin G (igg) Infusion System Is A Prescription Device Intended For Subcutaneous Delivery Of Immunoglobulin G (igg) In Accordance With The Fda Approved Labeling..

Submission Details

510(k) Number K142319 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 20, 2014
Decision Date May 14, 2015
Days to Decision 267 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code PKP - Immunoglobulin G (igg) Infusion System
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5725
Definition An Immunoglobulin G (igg) Infusion System Is A Prescription Device Intended For Subcutaneous Delivery Of Immunoglobulin G (igg) In Accordance With The Fda Approved Labeling.